98 related articles for article (PubMed ID: 18843021)
1. HSD17B1 genetic variants and hormone receptor-defined breast cancer.
Gaudet MM; Chanock S; Dunning A; Driver K; Brinton LA; Lissowska J; Peplonska B; Pharoah P; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2766-72. PubMed ID: 18843021
[TBL] [Abstract][Full Text] [Related]
2. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
Feigelson HS; Cox DG; Cann HM; Wacholder S; Kaaks R; Henderson BE; Albanes D; Altshuler D; Berglund G; Berrino F; Bingham S; Buring JE; Burtt NP; Calle EE; Chanock SJ; Clavel-Chapelon F; Colditz G; Diver WR; Freedman ML; Haiman CA; Hankinson SE; Hayes RB; Hirschhorn JN; Hunter D; Kolonel LN; Kraft P; LeMarchand L; Linseisen J; Modi W; Navarro C; Peeters PH; Pike MC; Riboli E; Setiawan VW; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D
Cancer Res; 2006 Feb; 66(4):2468-75. PubMed ID: 16489054
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
[TBL] [Abstract][Full Text] [Related]
4. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
5. Involvement of 17β-hydroxysteroid dehydrogenase type gene 1 937 A>G polymorphism in infertility in Polish Caucasian women with endometriosis.
Osiński M; Mostowska A; Wirstlein P; Skrzypczak J; Jagodziński PP; Szczepańska M
J Assist Reprod Genet; 2017 Jun; 34(6):789-794. PubMed ID: 28405865
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
Obazee O; Justenhoven C; Winter S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Hannelius U; Li J; Humphreys K; Hall P; Giles G; Severi G; Baglietto L; Southey M; Rabstein S; Harth V; Lotz A; Pesch B; Brüning T; Baisch C; Ko YD; Hamann U; Brauch H
Breast Cancer Res Treat; 2013 Apr; 138(2):543-8. PubMed ID: 23430226
[TBL] [Abstract][Full Text] [Related]
7. 17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.
Lutkowska A; Roszak A; Jagodziński PP
Pathol Oncol Res; 2017 Apr; 23(2):317-322. PubMed ID: 27571989
[TBL] [Abstract][Full Text] [Related]
8. HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore.
Wu AH; Seow A; Arakawa K; Van Den Berg D; Lee HP; Yu MC
Int J Cancer; 2003 Apr; 104(4):450-7. PubMed ID: 12584742
[TBL] [Abstract][Full Text] [Related]
9. Evidence for association of the rs605059 polymorphism of HSD17B1 gene with recurrent spontaneous abortions.
Ntostis P; Agiannitopoulos K; Tsaousis G; Pantos K; Lamnissou K
J Matern Fetal Neonatal Med; 2015; 28(18):2250-3. PubMed ID: 25394609
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of HSD17B1 Ser312Gly with Cancer Risk: Evidence from 66,147 Subjects.
Shi L; Yang X; Dong X; Zhang B
Twin Res Hum Genet; 2016 Apr; 19(2):136-45. PubMed ID: 26923943
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
Plourde M; Samson C; Durocher F; Sinilnokova O; Simard J;
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):115-28. PubMed ID: 18083510
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry.
Yang Y; Shu X; Shu XO; Bolla MK; Kweon SS; Cai Q; Michailidou K; Wang Q; Dennis J; Park B; Matsuo K; Kwong A; Park SK; Wu AH; Teo SH; Iwasaki M; Choi JY; Li J; Hartman M; Shen CY; Muir K; Lophatananon A; Li B; Wen W; Gao YT; Xiang YB; Aronson KJ; Spinell JJ; Gago-Dominguez M; John EM; Kurian AW; Chang-Claude J; Chen ST; Dörk T; Evans DGR; Schmidt MK; Shin MH; Giles GG; Milne RL; Simard J; Kubo M; Kraft P; Kang D; Easton DF; Zheng W; Long J
EBioMedicine; 2019 Oct; 48():203-211. PubMed ID: 31629678
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses.
Lissowska J; Gaudet MM; Brinton LA; Chanock SJ; Peplonska B; Welch R; Zatonski W; Szeszenia-Dabrowska N; Park S; Sherman M; Garcia-Closas M
Int J Cancer; 2007 Jun; 120(12):2696-703. PubMed ID: 17311260
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
17. Amplification of HSD17B1 and ERBB2 in primary breast cancer.
Gunnarsson C; Ahnström M; Kirschner K; Olsson B; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Oncogene; 2003 Jan; 22(1):34-40. PubMed ID: 12527905
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women.
Cong RJ; Huang ZY; Cong L; Ye Y; Wang Z; Zha L; Cao LP; Su XW; Yan J; Li YB
Arch Gynecol Obstet; 2012 Sep; 286(3):701-5. PubMed ID: 22546946
[TBL] [Abstract][Full Text] [Related]
19. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.
Feigelson HS; McKean-Cowdin R; Coetzee GA; Stram DO; Kolonel LN; Henderson BE
Cancer Res; 2001 Jan; 61(2):785-9. PubMed ID: 11212283
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women.
Sakoda LC; Blackston C; Doherty JA; Ray RM; Lin MG; Stalsberg H; Gao DL; Feng Z; Thomas DB; Chen C
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1066-73. PubMed ID: 18483327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
